Not just IgG4 antibodies that become predominant in the many-jabbed, but also lesser studied IgG2, researchers find. NIH ...

Early animal studies show that a single vaccine could protect the recipient from different variants of the coronaviruses that cause COVID-19, the flu and the common cold. In addition to creating ...

Conventionally, monoclonal antibodies (mAbs) were developed as a safe and effective anti-COVID-19 therapy ... binding domains resulted in drastic mAb efficacy reductions, thereby resulting ...